Description
50 Studies Every Endocrinologist Should Know assembles landmark, evidence-based studies in classic endocrinology to guide readers towards solving thorny endocrine problems. Featuring a diverse range of study types--including RCTs, multicenter trials, observational studies, and meta-analyses--this volume addresses the core issues faced by endocrinologists in clinical practice. Each chapter provides a concise summary of key studies, highlighting results, limitations, and practical implications. The chapters conclude with a list of major take-home points, which collectively form a foundation of Endocrine Principles that can be applied to real-word patient problems. As with all books in the "50 Studies" series, each study was selected using an objective selection criterion that included citations per year, high levels of evidence, clinical studies and trials, and a 3-stage Delphi review by international experts in the field. It is an indispensable reference for fellows, physicians, nurse practitioners, and any primary providers with an interest in endocrinology, as well as those taking both the endocrinology board exam and the Endocrinology, Diabetes, & Metabolism certification exam.
Table of Contents
SECTION 1: Conditions caused by Thyroid DamageChapter 1: Screening for Thyroid Disease in Early Pregnancy and in Pre-PregnancyChapter 2: Subclinical HypothyroidismChapter 3: Management of Thyroxine in Non-Ablated Patients with HypothyroidismChapter 4: Optimal Thyroid Replacement for the Athyreotic Patient SECTION 2: Conditions Causing Thyroid Overactivity Chapter 5: Antithyroid Drugs vs. Ablation in Community Treatment for Graves’ DiseaseChapter 6: Optimum Use of Antithyroid Drugs in HyperthyroidismChapter 7: Risks of I-131 Treatment of HyperthyroidismChapter 8: Hyperthyroidism caused by Amiodarone (AIT)SECTION 3: Focal and Structural Thyroid DiseaseChapter 9: Selection of Thyroid Nodules to be BiopsiedChapter 10: Selection of Patients over 45 for Thyroid BiopsyChapter 11: Molecular Genomic Testing (MGT) for Indeterminate Thyroid NodulesChapter 12: Complication Rate(s) from ThyroidectomyChapter 13: Ablation Techniques for Benign or Hot NodulesChapter 14: Microscopic Papillary Thyroid Carcinoma (mPTC) and Active Surveillance (AS)Chapter 15: Optimal Work-up and Surgery for a small, non-metastatic DTCAChapter 16: I-131 Treatment for DTCASECTION 4: Parathyroid DiseasesChapter 17: Active Surveillance and/or Medical Therapy for Hyperparathyroidism in Older PatientsChapter 18: Preoperative Localization of Sporadic Primary HyperparathyroidismChapter 19: Quality of Life after Surgery for Mild/Moderate Sporadic Primary HyperparathyroidismChapter 20: Secondary Hyperparathyroidism, Idiopathic Hypercalciuria, and Bone DensityChapter 21: Recurrent and/or Persistent Primary HyperparathyroidismSECTION 5: Metabolic Bone DiseaseChapter 22: Calcium and Vitamin D Effects on Bone MassChapter 23: Fracture Prevention in Patients with Low Bone MassChapter 24: Pretreatment Evaluation for OsteoporosisChapter 25: Evaluation of Fracture Risk in OsteoporosisChapter 26: Osteoporosis and Hip Fracture PreventionChapter 27: Alendronate and Fracture Risk ReductionChapter 28: Hip Fracture in the Elderly with Very Low Bone DensityChapter 29: Anabolic Agent(s) for OsteoporosisChapter 30: Glucocorticoid OsteoporosisChapter 31: Osteoporosis in MenSECTION 6: Adrenal ConditionsChapter 32: The Importance of Recognizing HyperaldosteronismChapter 33: Effectiveness of Treatment of HyperaldosteronismChapter 34: Screening for Adrenal InsufficiencyChapter 35: Adrenal IncidentalomasChapter 36: Opioid-Induced Endocrine DeficienciesChapter 37: Adrenal Insufficiency from Corticosteroid TreatmentChapter 38: Optimal Testing for ACTH-Dependent HypercortisolismSECTION 7: Pituitary Tumors / HypercortisolismChapter 39: Duration of Medical Treatment of Intrasellar ProlactinomasChapter 40: Acromegaly Treatment-Surgery, Medication, or What?Chapter 41: Primary Treatment of Pituitary HypercortisolismChapter 42: Treatment of Recurrent or Persistent HypercortisolismSECTION 8: Conditions Caused by Testosterone DeficiencyChapter 43: Risks of Testosterone Treatment in Older MenChapter 44: Male Obesity Secondary Hypogonadism (MOSH)SECTION 9: Conditions Related to Estrogen Deficiency Chapter 45: Estrogen Treatment and Cardiovascular HealthChapter 46: Estrogen Treatment and Skeletal HealthChapter 47: Estrogen + Progestin vs. Estrogen Alone, and NeoplasiaSECTION 10: Polycystic Ovary SyndromeChapter 48: Optimal Differential Diagnosis of PCOSChapter 49: Optimal Treatment of Hirsutism in PCOS Chapter 50: Treatment of Subfertility in PCOS
-
- 洋書電子書籍
- PET Image Quantific…
-
- 洋書電子書籍
- Integrating Motivat…
